Cargando…
Novel Therapeutic Strategies Applied to Pseudomonas aeruginosa Infections in Cystic Fibrosis
Cystic fibrosis (CF) is one of the most prevalent genetic diseases and a total of 1700 different genetic mutations can cause this condition. Patients that suffer this disease have a thickening of the mucus, creating an environment that promotes bacterial infections. Pseudomonas aeruginosa is a ubiqu...
Autores principales: | Chirgwin, Michael E., Dedloff, Margaret R., Holban, Alina Maria, Gestal, Monica C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6947192/ https://www.ncbi.nlm.nih.gov/pubmed/31817881 http://dx.doi.org/10.3390/ma12244093 |
Ejemplares similares
-
Conquering the host: Bordetella spp. and Pseudomonas aeruginosa molecular regulators in lung infection
por: Holban, Alina M., et al.
Publicado: (2022) -
Use of Biopolymers in Mucosally-Administered Vaccinations for Respiratory Disease
por: Dedloff, Margaret R., et al.
Publicado: (2019) -
Novel approaches to the treatment of Pseudomonas aeruginosa infections in cystic fibrosis
por: Hurley, Matthew N., et al.
Publicado: (2012) -
Management of refractory Pseudomonas aeruginosa infection in cystic fibrosis
por: Sordé, Roger, et al.
Publicado: (2011) -
Cystic fibrosis lung environment and Pseudomonas aeruginosa infection
por: Bhagirath, Anjali Y., et al.
Publicado: (2016)